Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Serial Chart Review of Repatha® Use in European Subjects With Hyperlipidaemia

NCT02770131 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02770131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02770131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Serial Chart Review of Repatha® Use in European Subjects With Hyperlipidaemia
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
May 4, 2016
Completion date
June 30, 2021
Enrollment
1,986 (actual)
Sites
183

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolaemia